Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function
Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are ri...
Gespeichert in:
Veröffentlicht in: | Journal of cellular biochemistry 2007-04, Vol.100 (6), p.1352-1369 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1369 |
---|---|
container_issue | 6 |
container_start_page | 1352 |
container_title | Journal of cellular biochemistry |
container_volume | 100 |
creator | Nicolson, Garth L. |
description | Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jcb.21247 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70305040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70305040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi1ERYfCghdAXiGxSOu_2IQdjKBQtcCi0KVlOzfCxYlTO4HO-_RB8WSmsOrqStfnO77Sh9ALSo4pIezk2tljRplQj9CKkkZVQgrxGK2I4qRinLJD9DTna0JI03D2BB1SxQSnVK3Q3QVMxsbgHc6boU2xB2yGFvd-iu5nLBtvAu7mwU0-Dm_xRQzg5mASTjAG46CHYVoSZijErW_LxHkex7A8ZTxFPCb4vcV66G0yA-AR0oJunUs4QZ5igge-fYYOOhMyPN_PI_T944fL9afq_Ovp5_W788oJplSlrKmZAC5pI6VSoLrGCMkUfyMZUGlE10hVW0u5IZaz1tZ1y0whaQM1MYofoVc775jizVxO0r3PDkIoN8c5a0U4qYkgBXy9A12KOSfo9Jh8b9JGU6K3lehSiV4qKezLvXS2PbT_yX0HBTjZAX98gM3DJn22fn-vrHYJnye4_Zcw6ZeWiqtaX3051euG_bj6dsk05X8BqImo-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70305040</pqid></control><display><type>article</type><title>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Nicolson, Garth L.</creator><creatorcontrib>Nicolson, Garth L.</creatorcontrib><description>Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.21247</identifier><identifier>PMID: 17243117</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; antioxidants ; Antioxidants - administration & dosage ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; atherosclerosis ; Cell Membrane - drug effects ; Cell Membrane - metabolism ; diabetes ; dietary supplement ; fatigue ; heart disease ; Humans ; lipids ; liver disease ; Metabolic Syndrome - metabolism ; Metabolic Syndrome - physiopathology ; Metabolic Syndrome - prevention & control ; mitochondria ; Mitochondria - drug effects ; Mitochondria - physiology ; Models, Biological ; Oxidation-Reduction - drug effects ; Oxidative Stress - drug effects ; renal disease ; vascular inflammation</subject><ispartof>Journal of cellular biochemistry, 2007-04, Vol.100 (6), p.1352-1369</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</citedby><cites>FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.21247$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.21247$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17243117$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nicolson, Garth L.</creatorcontrib><title>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>antioxidants</subject><subject>Antioxidants - administration & dosage</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>atherosclerosis</subject><subject>Cell Membrane - drug effects</subject><subject>Cell Membrane - metabolism</subject><subject>diabetes</subject><subject>dietary supplement</subject><subject>fatigue</subject><subject>heart disease</subject><subject>Humans</subject><subject>lipids</subject><subject>liver disease</subject><subject>Metabolic Syndrome - metabolism</subject><subject>Metabolic Syndrome - physiopathology</subject><subject>Metabolic Syndrome - prevention & control</subject><subject>mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - physiology</subject><subject>Models, Biological</subject><subject>Oxidation-Reduction - drug effects</subject><subject>Oxidative Stress - drug effects</subject><subject>renal disease</subject><subject>vascular inflammation</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAURi1ERYfCghdAXiGxSOu_2IQdjKBQtcCi0KVlOzfCxYlTO4HO-_RB8WSmsOrqStfnO77Sh9ALSo4pIezk2tljRplQj9CKkkZVQgrxGK2I4qRinLJD9DTna0JI03D2BB1SxQSnVK3Q3QVMxsbgHc6boU2xB2yGFvd-iu5nLBtvAu7mwU0-Dm_xRQzg5mASTjAG46CHYVoSZijErW_LxHkex7A8ZTxFPCb4vcV66G0yA-AR0oJunUs4QZ5igge-fYYOOhMyPN_PI_T944fL9afq_Ovp5_W788oJplSlrKmZAC5pI6VSoLrGCMkUfyMZUGlE10hVW0u5IZaz1tZ1y0whaQM1MYofoVc775jizVxO0r3PDkIoN8c5a0U4qYkgBXy9A12KOSfo9Jh8b9JGU6K3lehSiV4qKezLvXS2PbT_yX0HBTjZAX98gM3DJn22fn-vrHYJnye4_Zcw6ZeWiqtaX3051euG_bj6dsk05X8BqImo-Q</recordid><startdate>20070415</startdate><enddate>20070415</enddate><creator>Nicolson, Garth L.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070415</creationdate><title>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</title><author>Nicolson, Garth L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>antioxidants</topic><topic>Antioxidants - administration & dosage</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>atherosclerosis</topic><topic>Cell Membrane - drug effects</topic><topic>Cell Membrane - metabolism</topic><topic>diabetes</topic><topic>dietary supplement</topic><topic>fatigue</topic><topic>heart disease</topic><topic>Humans</topic><topic>lipids</topic><topic>liver disease</topic><topic>Metabolic Syndrome - metabolism</topic><topic>Metabolic Syndrome - physiopathology</topic><topic>Metabolic Syndrome - prevention & control</topic><topic>mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - physiology</topic><topic>Models, Biological</topic><topic>Oxidation-Reduction - drug effects</topic><topic>Oxidative Stress - drug effects</topic><topic>renal disease</topic><topic>vascular inflammation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nicolson, Garth L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nicolson, Garth L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2007-04-15</date><risdate>2007</risdate><volume>100</volume><issue>6</issue><spage>1352</spage><epage>1369</epage><pages>1352-1369</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17243117</pmid><doi>10.1002/jcb.21247</doi><tpages>18</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2007-04, Vol.100 (6), p.1352-1369 |
issn | 0730-2312 1097-4644 |
language | eng |
recordid | cdi_proquest_miscellaneous_70305040 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Animals antioxidants Antioxidants - administration & dosage Antioxidants - pharmacology Antioxidants - therapeutic use atherosclerosis Cell Membrane - drug effects Cell Membrane - metabolism diabetes dietary supplement fatigue heart disease Humans lipids liver disease Metabolic Syndrome - metabolism Metabolic Syndrome - physiopathology Metabolic Syndrome - prevention & control mitochondria Mitochondria - drug effects Mitochondria - physiology Models, Biological Oxidation-Reduction - drug effects Oxidative Stress - drug effects renal disease vascular inflammation |
title | Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A53%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20syndrome%20and%20mitochondrial%20function:%20Molecular%20replacement%20and%20antioxidant%20supplements%20to%20prevent%20membrane%20peroxidation%20and%20restore%20mitochondrial%20function&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Nicolson,%20Garth%20L.&rft.date=2007-04-15&rft.volume=100&rft.issue=6&rft.spage=1352&rft.epage=1369&rft.pages=1352-1369&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.21247&rft_dat=%3Cproquest_cross%3E70305040%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70305040&rft_id=info:pmid/17243117&rfr_iscdi=true |